Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Treasury Shares: 2010-2024

Historic Treasury Shares for Cumberland Pharmaceuticals (CPIX) over the last 15 years, with Dec 2024 value amounting to $339,200.

  • Cumberland Pharmaceuticals' Treasury Shares fell 78.57% to $58,947 in Q3 2025 from the same period last year, while for Sep 2025 it was $58,947, marking a year-over-year decrease of 78.57%. This contributed to the annual value of $339,200 for FY2024, which is 15.65% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Treasury Shares stood at $339,200 for FY2024, which was down 15.65% from $402,143 recorded in FY2023.
  • Cumberland Pharmaceuticals' Treasury Shares' 5-year high stood at $779,415 during FY2020, with a 5-year trough of $339,200 in FY2024.
  • Its 3-year average for Treasury Shares is $379,031, with a median of $395,751 in 2022.
  • In the last 5 years, Cumberland Pharmaceuticals' Treasury Shares crashed by 30.35% in 2022 and then climbed by 1.62% in 2023.
  • Cumberland Pharmaceuticals' Treasury Shares (Yearly) stood at $779,415 in 2020, then declined by 27.10% to $568,181 in 2021, then plummeted by 30.35% to $395,751 in 2022, then increased by 1.62% to $402,143 in 2023, then dropped by 15.65% to $339,200 in 2024.